|
1
|
Kikuchi Y, Hirota M, Iwai T, et al:
Salivary duct carcinoma in the mandible: a case report. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod. 103:e41–e46. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barnes L, Eveson JW, Reichart P and
Sidransky D: World Health Organization Classification of Tumors.
Pathology and Genetics of Head and Neck Tumors. IARC Press; Lyon:
2005
|
|
3
|
Jaehne M, Roeser K, Jaekel T, Schepers JD,
Albert N and Löning T: Clinical and immunohistologic typing of
salivary duct carcinoma: a report of 50 cases. Cancer.
103:2526–2533. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cornolti G, Ungari M, Morassi ML, et al:
Amplification and overexpression of HER2/neu gene and HER2/neu
protein in salivary duct carcinoma of the parotid gland. Arch
Otolaryngol Head Neck Surg. 133:1031–1036. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Salovaara E, Hakala O, Bäck L, et al:
Management and outcome of salivary duct carcinoma in major salivary
glands. Eur Arch Otorhinolaryngol. 270:281–285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guzzo M, Di Palma S, Grandi C and Molinari
R: Salivary duct carcinoma: clinical characteristics and treatment
strategies. Head Neck. 19:126–133. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thompson LD: Salivary duct carcinoma. Ear
Nose Throat J. 91:356–359. 2012.PubMed/NCBI
|
|
8
|
Greene FL, Page DL, Fleming ID, et al:
AJCC Cancer Staging Manual. 6th. Springer; New York, NY: 2002
|
|
9
|
Lewis JE, McKinney BC, Weil LH, Ferreiro
JA and Olsen KD: Salivary duct carcinoma Clinicopathologic and
immunohistochemical review of 26 cases. Cancer. 77:223–230. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barnes L, Rao U, Krause J, Contis L,
Schwartz A and Scalamogna P: Salivary duct carcinoma. Part I. A
clinicopathologic evaluation and DNA image analysis of 13 cases
with review of the literature. Oral Surg Oral Med Oral Pathol.
78:64–73. 1994.PubMed/NCBI
|
|
11
|
Jaspers HC, Verbist BM, Schoffelen R, et
al: Androgen receptor-positive salivary duct carcinoma: a disease
entity with promising new treatment options. J Clin Oncol.
29:e473–e476. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Laurie SA and Licitra L: Systemic therapy
in the palliative management of advanced salivary gland cancers. J
Clin Oncol. 24:2673–2678. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moriki T, Ueta S, Takahashi T, Mitani M
and Ichien M: Salivary duct carcinoma: cytologic characteristics
and application of androgen receptor immunostaining for diagnosis.
Cancer. 93:344–350. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim JY, Lee S, Cho KJ, et al: Treatment
results of post-operative radiotherapy in patients with salivary
duct carcinoma of the major salivary glands. Br J Radiol.
85:e947–e952. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nashed M and Casasola RJ: Biological
therapy of salivary duct carcinoma. J Laryngol Otol. 123:250–252.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
de Potter CR: The neu-oncogene: more than
a prognostic indicator? Hum Pathol. 25:1264–1268. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Skálová A, Stárek I, Vanecek T, et al:
Expression of HER-2/neu gene and protein in salivary duct
carcinomas of parotid gland as revealed by fluorescence in-situ
hybridization and immunohistochemistry. Histopathology. 42:348–356.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wee DT, Thomas AA and Bradley PJ: Salivary
duct carcinoma: what is already known, and can we improve survival?
J Laryngol Otol. 126(Suppl 2): S2–S7. 2012.PubMed/NCBI
|
|
19
|
Nagao T, Gaffey TA, Visscher DW, et al:
Invasive micropapillary salivary duct carcinoma: a distinct
histologic variant with biologic significance. Am J Surg Pathol.
28:319–326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto H, Uryu H, Segawa Y and
Tsuneyoshi M: Aggressive invasive micropapillary salivary duct
carcinoma of the parotid gland. Pathol Int. 58:322–326. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Johnson CJ, Barry MB, Vasef MA and Deyoung
BR: Her-2/neu expression in salivary duct carcinoma: an
immunohistochemical and chromogenic in situ hybridization study.
Appl Immunohistochem Mol Morphol. 16:54–58. 2008.PubMed/NCBI
|
|
22
|
Nabili V, Tan JW, Bhuta S, Sercarz JA and
Head CS: Salivary duct carcinoma: a clinical and histologic review
with implications for trastuzumab therapy. Head Neck. 29:907–912.
2007. View Article : Google Scholar : PubMed/NCBI
|
